Rheumatoid arthritis affects about 1% of the world’s population. Claire Kaiser’s project aims to develop a wearable, noninvasive device for targeted ultrasound of neural pathways within the spleen combined with noninvasive electrical stimulation of the vagus nerve to treat rheumatoid arthritis. The project vision is to create a start-up company in Minnesota to develop novel autonomic neuromodulation technologies that combine targeted ultrasound and electrical stimulation for treating rheumatoid arthritis patients and other pain and autoimmune conditions.
Discoveries Through Industry Partnerships Fellow: Claire Kaiser, Biomedical Engineering
Mentor: Hubert Lim, Otolaryngology
Industry Partner: The Ultran Group, Anuj Bhardwaj